CidaraLogo (1).jpg
Cidara Therapeutics Announces Pricing of Public Offering of Common Stock
October 07, 2016 09:00 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 07, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing...
CidaraLogo (1).jpg
Cidara Therapeutics to Present at the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
September 20, 2016 16:05 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Reports Second Quarter 2016 Financial Results and Provides Corporate Update
August 11, 2016 16:12 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Therapeutics to Present at the Cantor Fitzgerald Annual Healthcare Conference
July 06, 2016 07:00 ET | Cidara Therapeutics, Inc.
SAN DIEGO, July 06, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Therapeutics Expands Management Team
July 05, 2016 07:00 ET | Cidara Therapeutics, Inc.
SAN DIEGO, July 05, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Therapeutics to Present at the Jefferies 2016 Healthcare Conference
June 02, 2016 08:00 ET | Cidara Therapeutics, Inc.
SAN DIEGO, June 02, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Reports First Quarter 2016 Financial Results and Provides Corporate Update
May 12, 2016 17:12 ET | Cidara Therapeutics, Inc.
SAN DIEGO, May 12, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Therapeutics to Present at the Needham & Company 15th Annual Healthcare Conference
April 05, 2016 07:30 ET | Cidara Therapeutics, Inc.
SAN DIEGO, April 05, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update
March 18, 2016 07:30 ET | Cidara Therapeutics, Inc.
SAN DIEGO, March 18, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Therapeutics Announces Pricing of Initial Public Offering
April 15, 2015 07:30 ET | Cidara Therapeutics, Inc.
SAN DIEGO, April 15, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...